BR112018000497A2 - processo para preparação de um composto - Google Patents

processo para preparação de um composto

Info

Publication number
BR112018000497A2
BR112018000497A2 BR112018000497A BR112018000497A BR112018000497A2 BR 112018000497 A2 BR112018000497 A2 BR 112018000497A2 BR 112018000497 A BR112018000497 A BR 112018000497A BR 112018000497 A BR112018000497 A BR 112018000497A BR 112018000497 A2 BR112018000497 A2 BR 112018000497A2
Authority
BR
Brazil
Prior art keywords
derivative
compound
cannabidiol compound
dihalo
cannabidiol
Prior art date
Application number
BR112018000497A
Other languages
English (en)
Inventor
Petrovic Denis
Dialer Lukas
Weigl Ulrich
Original Assignee
Noramco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57730761&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112018000497(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Noramco Inc filed Critical Noramco Inc
Publication of BR112018000497A2 publication Critical patent/BR112018000497A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/11—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/11—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
    • C07C37/14—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms by addition reactions, i.e. reactions involving at least one carbon-to-carbon unsaturated bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

a presente revelação se refere à preparação de um composto de canabidiol ou um derivado do mesmo. o composto de canabidiol, ou derivados do mesmo, pode ser preparado por meio de uma reação catalisada por ácido de um di-halo-olivetol adequadamente selecionado e substituído, ou um derivado do mesmo, com um alceno cíclico adequadamente selecionado e substituído para produzir um composto de dihalo-canabidiol ou um derivado do mesmo. o composto de dihalo-canabidiol ou o derivado do mesmo pode ser produzido com alto rendimento, alta estereoespecificidade ou ambos. o mesmo pode ser, então, convertido sob condições redutoras em um composto de canabidiol ou derivados do mesmo.
BR112018000497A 2015-07-10 2016-07-01 processo para preparação de um composto BR112018000497A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562191097P 2015-07-10 2015-07-10
US15/199,528 US10059683B2 (en) 2015-07-10 2016-06-30 Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
PCT/US2016/040635 WO2017011210A1 (en) 2015-07-10 2016-07-01 Process for the production of cannabidiol and delta-9-tetrahydrocannabinol

Publications (1)

Publication Number Publication Date
BR112018000497A2 true BR112018000497A2 (pt) 2018-09-11

Family

ID=57730761

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018000497A BR112018000497A2 (pt) 2015-07-10 2016-07-01 processo para preparação de um composto

Country Status (21)

Country Link
US (4) US20170008869A1 (pt)
EP (2) EP3722276A1 (pt)
JP (2) JP6810842B2 (pt)
CN (1) CN108137526A (pt)
AU (2) AU2016294264B2 (pt)
BR (1) BR112018000497A2 (pt)
CA (1) CA2992043C (pt)
CL (2) CL2018000079A1 (pt)
CO (1) CO2018001290A2 (pt)
CR (1) CR20180094A (pt)
DK (1) DK3319952T3 (pt)
EC (1) ECSP18010065A (pt)
ES (1) ES2784881T3 (pt)
HK (1) HK1255390A1 (pt)
IL (1) IL256750A (pt)
MX (1) MX2018000354A (pt)
MY (1) MY182971A (pt)
NZ (1) NZ738925A (pt)
PH (1) PH12018500093A1 (pt)
PT (1) PT3319952T (pt)
WO (1) WO2017011210A1 (pt)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2530001B (en) 2014-06-17 2019-01-16 Gw Pharma Ltd Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
GB2531281A (en) 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabidiol in the treatment of intractable epilepsy
US20170008869A1 (en) * 2015-07-10 2017-01-12 Noramco, Inc. Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
US10640482B2 (en) 2017-07-21 2020-05-05 University Of South Florida Synthesis of cannabinoids
WO2019152736A1 (en) 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
CA3091088A1 (en) * 2018-02-13 2019-08-22 Beetlebung Pharma Ltd. Cannabinoid derivatives and conjugates and uses thereof
HUE060229T2 (hu) * 2018-02-20 2023-02-28 Mymd Pharmaceuticals Inc Genetikailag módosított cannabis sativa növények és módosított kannabinoid vegyületek a kábítószer-függõség és más rendellenességek kezelésére
CN112292368B (zh) 2018-06-28 2024-02-02 西姆莱斯有限公司 （+）-大麻素类的合成及其治疗作用
US10736869B2 (en) 2018-07-16 2020-08-11 ECS Health Sciences, Inc. Compositions and methods related to cannabinoids, terpenoids and essential oils
CN108863768A (zh) * 2018-08-03 2018-11-23 上海华堇生物技术有限责任公司 3,5-二甲氧基苯甲酰氯的制备方法
KR20210093231A (ko) 2018-08-20 2021-07-27 베서, 파마 엘엘씨 칸나비노이드의 생성 공정
WO2020051371A2 (en) * 2018-09-05 2020-03-12 Noramco, Inc. Cannabidiol compositions having modified cannabinoid profiles
US11040932B2 (en) 2018-10-10 2021-06-22 Treehouse Biotech, Inc. Synthesis of cannabigerol
EP3653596A1 (en) * 2018-11-14 2020-05-20 Indena S.p.A. Continuous flow synthesis of cannabidiol
DE102019104563A1 (de) * 2019-02-22 2020-08-27 Chiracon Gmbh Verfahren zur Herstellung von Cannabidiol
CN109970516A (zh) * 2019-03-20 2019-07-05 栾云鹏 一种工业化制备高纯度高收率的大麻酚类物质的合成方法
US10981850B2 (en) 2019-04-15 2021-04-20 Trustees Of Boston University One-step flow-mediated synthesis of cannabidiol (CBD) and derivatives
CN111943813B (zh) 2019-05-17 2023-04-14 上海特化医药科技有限公司 大麻二酚类化合物的制备方法
CA3179235A1 (en) * 2019-05-23 2020-11-26 Kare Chemical Technologies Inc. Catalytic cannabinoid processes and precursors
AU2020283130A1 (en) * 2019-05-31 2022-01-27 Purisys Llc Processes for the preparation of halogenated dihydroxybenzene compounds
EP4067330B1 (en) 2019-06-11 2024-03-20 Symrise AG Cosmetic use of cannabigerol
WO2020252277A1 (en) * 2019-06-13 2020-12-17 Isomerz, Inc. Making delta 8 thc, delta 10 thc and/or cannabinol from cbd
WO2020252369A1 (en) * 2019-06-14 2020-12-17 Purisys Llc Crystalline cannabigerol
US11542243B1 (en) 2019-09-26 2023-01-03 FusionFarms, LLC Method of converting delta9-THC to delta10-THC and the purification of the delta10-THC by crystallization
WO2021113083A1 (en) 2019-12-06 2021-06-10 JLABS Beauty LLC Topical compositions containing rose oil and cannabidiol and methods of making and using the same
CA3162971A1 (en) * 2019-12-27 2021-07-01 Charles K. Marlowe Preparation of cannabichromene and related cannabinoids
WO2021139740A1 (zh) * 2020-01-08 2021-07-15 成都百裕制药股份有限公司 四氢大麻酚衍生物及其制备方法和在医药上的应用
US20230002425A1 (en) * 2020-01-08 2023-01-05 Chengdu Baiyu Pharmaceutical Co., Ltd. Cannabidiol derivatives, preparation method thereof and use thereof
EP4089084A4 (en) * 2020-01-08 2024-03-13 Chengdu Baiyu Pharmaceutical Co Ltd CANNABIDIOL DERIVATIVE AND ITS PREPARATION METHOD AND ITS MEDICAL USE
WO2021150885A1 (en) * 2020-01-24 2021-07-29 Perkinelmer Health Sciences, Inc. Cannabinoid derivatives
US10981849B1 (en) * 2020-02-20 2021-04-20 Sci Pharmtech Inc. Method for preparing cannabinoids
GB202002754D0 (en) 2020-02-27 2020-04-15 Gw Res Ltd Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
AU2021235467A1 (en) 2020-03-12 2021-10-07 Council Of Scientific And Industrial Research Process for the synthesis of cannabidiol and intermediates thereof
JP2023520794A (ja) * 2020-03-31 2023-05-19 フィトセラピューティクス・リミテッド テルペンフェノール化合物およびそれらの使用
EP4153306A1 (en) 2020-05-22 2023-03-29 Ilera Derm LLC Compositions for treating acne and dermatological conditions
CN112094257B (zh) * 2020-08-19 2023-08-22 公安部禁毒情报技术中心 一种△-9四氢大麻酚的制备方法
CN112811980B (zh) * 2020-12-01 2022-03-25 山东金城金奥医药科技有限公司 一种绿色光氧化连续制备大麻二酚中间体的方法
EP4263514A2 (en) 2020-12-17 2023-10-25 Nalu Bio, Inc. Synthesis of cannabidiol and analogs thereof, and related compounds, formulations, and methods of use
US11242330B1 (en) * 2021-02-25 2022-02-08 Acid Neutral Alkaline Laboratory Organic catalyst and method for preparation of aromatic tricyclic pyrans
US11242328B1 (en) * 2021-02-25 2022-02-08 Acid Neutral Alkaline Laboratory Heterogeneous catalyst and method for preparation of aromatic tricyclic pyrans
US20220306598A1 (en) * 2021-03-25 2022-09-29 Precision Extraction Corporation Method for highly selective conversion of cbd to delta-8 thc
US11352337B1 (en) * 2021-06-02 2022-06-07 Acid Neutral Alkaline Laboratory Zeolite catalyst and method for preparation of aromatic tricyclic pyrans
CN113603568A (zh) * 2021-07-19 2021-11-05 厦门朝阳生物工程有限公司 一种大麻二酚的制备方法
WO2023086447A2 (en) * 2021-11-12 2023-05-19 Pureform Global, Inc. A method for the synthesis of cannabinol
WO2024028516A1 (en) 2022-08-05 2024-02-08 Salud & Semillas, S.L. CANNABINOID SYNTHESIS STARTING OUT FROM OLIVETOL AND TERPENE IN DICHLOROMETHANE WITH FeCl3 * 6H2O AS CATALYST

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH473075A (de) 1966-11-04 1969-05-31 Theodor Dr Petrzilka Verfahren zur Herstellung von in 2-Stellung substituierten Resorcinderivaten
DE4100441A1 (de) 1991-01-09 1992-07-16 Mack Chem Pharm Verfahren zur herstellung von 6,12-dihydro-6-hydroxy-cannabidiol und dessen verwendung zur herstellung von trans-delta-9-tetrahydrocannabinol
WO2001003690A1 (en) 1999-07-12 2001-01-18 Virginia Commonwealth University Novel vasodilator cannabinoid analogs
EP1482917B1 (en) * 2002-02-01 2019-05-08 GW Pharma Limited Compositions comprising cannabidiolic acid for treatment of nausea, vomiting, emesis, motion sickness or like conditions
GB2393182B (en) * 2002-09-23 2007-03-14 Gw Pharma Ltd Method of preparing cannabidiol from plant material
US7169942B2 (en) * 2003-05-20 2007-01-30 University Of Tennessee Research Foundation Cannabinoid derivatives, methods of making, and use thereof
US7323576B2 (en) 2004-10-01 2008-01-29 Alphora Research Inc. Synthetic route to dronabinol
TWI369203B (en) * 2004-11-22 2012-08-01 Euro Celtique Sa Methods for purifying trans-(-)-△9-tetrahydrocannabinol and trans-(+)-△9-tetrahydrocannabinol
DE102005028937B4 (de) * 2005-06-22 2009-07-23 Bionorica Ag Verfahren zur Herstellung von Dronabinol
ZA200802767B (en) * 2005-09-29 2009-09-30 Amr Technology Inc Process for production of delta-9-tetrahydrocannabinol
CA2751741C (en) * 2008-02-06 2018-07-10 Mallinckrodt Inc. Process for the preparation of (-) -delta 9-tetrahydrocannabinol
DE102009019322A1 (de) * 2009-04-30 2010-11-11 The Health Concept Gmbh Verfahren zur Herstellung von Synthetischen Cannabinoiden
EP3274321B8 (en) * 2015-03-23 2019-10-23 Echo Pharmaceuticals B.V. Cannabidiol isolate from industrial-hemp and use thereof in pharmaceutical and/or cosmetic preparations
AU2016267585C1 (en) * 2015-05-28 2023-02-16 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
US20170008869A1 (en) * 2015-07-10 2017-01-12 Noramco, Inc. Process for the production of cannabidiol and delta-9-tetrahydrocannabinol

Also Published As

Publication number Publication date
CA2992043C (en) 2020-04-14
ECSP18010065A (es) 2018-05-31
CO2018001290A2 (es) 2018-04-19
JP2018522944A (ja) 2018-08-16
AU2016294264B2 (en) 2019-06-13
CR20180094A (es) 2018-06-14
MY182971A (en) 2021-02-05
EP3319952B8 (en) 2020-03-11
HK1255390A1 (zh) 2019-08-16
AU2016294264A1 (en) 2018-02-01
EP3319952B1 (en) 2020-02-05
NZ738925A (en) 2019-05-31
MX2018000354A (es) 2018-08-15
US20180319763A1 (en) 2018-11-08
US10059683B2 (en) 2018-08-28
PT3319952T (pt) 2020-04-22
EP3722276A1 (en) 2020-10-14
AU2019229416A1 (en) 2019-10-03
PH12018500093A1 (en) 2018-07-09
JP6810842B2 (ja) 2021-01-13
DK3319952T3 (da) 2020-03-23
US20170008869A1 (en) 2017-01-12
EP3319952A1 (en) 2018-05-16
CA2992043A1 (en) 2017-01-19
US20210061781A1 (en) 2021-03-04
WO2017011210A1 (en) 2017-01-19
US10844035B2 (en) 2020-11-24
JP2020037596A (ja) 2020-03-12
IL256750A (en) 2018-03-29
CN108137526A (zh) 2018-06-08
US20170008868A1 (en) 2017-01-12
ES2784881T3 (es) 2020-10-01
CL2019003154A1 (es) 2020-03-06
CL2018000079A1 (es) 2018-08-24

Similar Documents

Publication Publication Date Title
BR112018000497A2 (pt) processo para preparação de um composto
BR112016028219A2 (pt) composto, método de tratamento ou prevenção do câncer, de uma doença infecciosa, ou de uma doença designada por aberração de metabolismo de energia celular em um indivíduo, método de tratamento ou prevenção de leucemia, câncer de pulmão de não pequenas células, carcinoma hepatocelular, ou glioblastomas em um indivíduo, método de tratamento de uma doença ou distúrbio em um indivíduo, composição farmacêutica e processo para obtenção de um composto de fórmula (i)
BR112017022488A2 (pt) produção microbiana de terpenoides
BR112017009701A2 (pt) composto e métodos para a preparação de um composto
BR112015017606A2 (pt) composição, método de produzir a composição, utilização da composição e combustível obtido a partir da composição
BR112012026256A8 (pt) Métodos para produção de biocombustível
BR112012021438A8 (pt) Sistema catalisador para uso em polimerização olefínica e processo para polimerizar ou copolimerizar uma olefina
BR112015031913A2 (pt) processo para a fabricação de amino-benzoxazinonas 4-propargilatadas e sua utilização
BR112015008037A2 (pt) compostos, processo para a preparação de um composto, composição farmacêutica, utilização do composto, método para o tratamento do câncer e invenção
BR112015016103A2 (pt) processo para preparar ésteres cíclicos e amidas cíclicas
BR112014026053A2 (pt) método de preparo de para-xileno a partir de biomassa
BR112016013316A8 (pt) método para a produção de furfural e uso de ácido metanossulfônico
BR112015019278A2 (pt) processo de elastografia multi-impulsional
BR112019002192A2 (pt) método para produzir cetoenóis cíclicos substituídos por espirocetal
BR112017010654A2 (pt) processos para conversão de ácido mevalônico biologicamente derivado
BR112019025028A2 (pt) Método para preparar um composto.
BR112015028887A2 (pt) métodos para preparação de um poliéster
BR112016025791A2 (pt) microrganismo modificado, método para produzir um composto orgânico e uso de um microrganismo modificado
BR112017001847A2 (pt) processo para a preparação de um composto de fórmula (i), mistura, composição e composto de fórmula (ii)
BR112014009390A2 (pt) corantes ácidos de trisazóicos
BR112015015798A2 (pt) método para a preparação de um composto
BR112015015229A8 (pt) processo para a preparação de um composto da fórmula, e, composto
BR112016016397A2 (pt) método para preparar 1-alquil-3-difluorometil-5-fluoro-1h-pirazol-4-carbaldeídos e 1-alquil-3-difluorometil-5-fluoro-1h-pirazol-4-carboxilatos.
BR112017010932A2 (pt) método para recuperar cristais de ácido succínico com o uso de tensoativos durante a cristalização e cristais resultantes
BR112016022437A2 (pt) Processo para preparação de (2s,5r)-6-(benziloxi)-7-oxo-1,6- diazabiciclo[3,2,1]octano-2-carboxilato de sódio

Legal Events

Date Code Title Description
B15N Others concerning applications: notification of judicial decision

Free format text: VARA: 25A VARA FEDERAL DO RIO DE JANEIROPROCESSO N.O 5022017-09.2019.4.02.5101) - NUP: 00408.027367/2019-14IMPETRANTE: KASZNAR LEONARDOS ADVOGADOSIMPETRADO: PRESIDENTE DO INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI?ANTE O EXPOSTO, DENEGO O MANDADO DE SEGURANCA E JULGO EXTINTO O PROCESSO SEM RESOLUCAO DO MERITO, COM FULCRO NO ARTIGO 6O, 5O, DA LEI NO 12.016/2009 C/C ARTIGO 485, VI DO CODIGO DE PROCESSO CIVIL.?

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C07D 311/04 , C07D 311/80

Ipc: C07D 311/04 (2006.01), C07D 311/80 (2006.01), C07D

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO EM FUNCAO DA REVOGACAO DO ART. 229-C DA LEI NO 9.279, DE 1996, POR FORCA DA LEI NO 14.195, DE 2021

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements